CAS: 5696-15-1; 2-(Tert-Butylamino)-1-(2,5-Dimethoxyphenyl)Propan-1-Ol,Hydrochloride

该化合物是一种化学化合物,被归类为选择性乙型-2肾上腺对抗物,主要因其在药理研究中的作用而得到承认,特别是在与哮喘和其他呼吸条件有关的研究中,该物质的特点在于能够阻塞乙型-2肾上腺受体,这种受体是支气管滑动肌肉松动的一部分.这一行动可以影响空气阻力,并影响治疗应用.丁氧胺盐通常被作为白色的脱白晶体粉末展示,在水和酒精中可溶解,因此适合各种配方.其分子结构包括一种丁氧化合物组,有助于其药理特性.与许多化学物质一样,安全和处理预防措施必不可少,因为它在生物系统中使用时可能会产生副作用或相互作用.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-8815883-B2
    优先权日:2009-11-02
    标 题 :Compounds and methods for inhibiting serotonin synthesis
    发明人:LANDRY DONALD; DENG SHI-XIAN
    权利人:LANDRY DONALD; DENG SHI-XIAN; TRUSTEES OF COLUMBIA UNVIERSITY IN THE CITY OF NEW YORK
    摘要:Compounds having the structures below that are TPH1 inhibitors are provided: The compounds are useful of, e.g., to increase bone mass. In preferred embodiments, the patient is known to have, or to be at risk for, a low bone mass disease such as osteoporosis.

    专利号:US-7888116-B2
    优先权日:2004-07-22
    标 题 :Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases
    发明人:EGAN JOSEPHINE M; DOYLE MAIRE E
    权利人:US HEALTH
    摘要:Disclosed are methods for identifying and isolating a precursor cell. Also, disclosed are methods of increasing insulin synthesis from a pancreatic B-cell. Further, disclosed are methods of improving pancreatic B-cell function. Still further, disclosed are methods of preventing or delaying the onset of a metabolic disease, methods of treating or preventing a metabolic disease in a subject, and to compositions for treating or preventing a metabolic disease in a subject in need of such treatment or prevention.

    专利号:CN-101486668-B
    优先权日:2003-12-30
    标题 :Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof

    专利号:WO-2014063189-A1
    优先权日:2012-10-23
    标题 :Methods and products for preventing and/or treating a stress induced cardiomyopathy
    发明人:HOROWITZ JOHN; CHIRKOV YULIY
    权利人:ADELAIDE RES & INNOVATION PTY
    摘要:The present disclosure relates to methods and products for preventing and/or treating a stress- induced cardiomyopathy. Certain embodiments of the present disclosure provide a method of preventing and/or treating a stress-induced cardiomyopathy in a subject, the method comprising administering to the subject a therapeutically effective amount of one or more of the following agents: a peroxynitrite inhibitor; an inhibitor of peroxynitrite synthesis; an inhibitor of peroxynitrite associated signalling; an inhibitor of peroxynitrite-induced DNA damage; a Tx NIP inhibitor; a beta 2 adrenoceptor antagonist; and a beta 3 adrenoceptor antagonist; thereby preventing and/or treating the stress-induced cardiomyopathy in the subject.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Arai M, Sato T, Takeuchi S, Goto S, Togari A. Dose effects of butoxamine, a selective β2-adrenoceptor antagonist, on bone metabolism in spontaneously hypertensive rat. Eur J Pharmacol. 2013 Feb 15;701(1-3):7-13. doi: 10.1016/j.ejphar.2012.12.016. Epub 2013 Jan 12. doi: 10.1177/0022034514536730. Epub 2014 May 27.
    3: Gulia KK, Mallick HN, Kumar VM. Atenolol or butoxamine injection at the lateral septum doesn't inhibit male sexual behavior in rats. Indian J Physiol Pharmacol. 2005 Jan;49(1):103-7. doi: 10.1097/SHK.0b013e31822413a4. doi: 10.1016/j.ejphar.2015.02.031. Epub 2015 Feb 25. German. doi: 10.1111/nmo.12564. Epub 2015 Apr 5. doi: 10.1371/journal.pone.0094726. eCollection 2014.
    13: Peng XY, Huang Y, Wang XL, Cao LF, Chen LH, Luo WF, Liu T. Adrenergic β2-receptor mediates itch hypersensitivity following heterotypic chronic stress in rats. Neuroreport. 2015 Dec 2;26(17):1003-10. doi: 10.1097/WNR.0000000000000458. doi: 10.1523/JNEUROSCI.1974-13.2013.

    合成参考文献


    参考文献:10.1016/j.bbrc.2023.08.050
    摘要:Ikeda Y, Davis MI, Sumita K, Zheng Y, Kofuji S, Sasaki M, Hirota Y, Pragani R, Shen M, Boxer MB, Takeuchi K, Senda T, Simeonov A, Sasaki AT. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells. Biochemical and Biophysical Research Communications. 2023 Oct;679():116–21. doi: 10.1016/j.bbrc.2023.08.050.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知